EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 17 lipnja 2024. Database contains 4917 unique substances/entries.
Filter the list

 
266-578-3
67118-55-2
E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment)
HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)
Details
-
-
E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment)
HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)
Details
-
95342-41-9
END Endocrine disrupting properties (Article 57(f) - human health)
Details
-
852541-21-0
END Endocrine disrupting properties (Article 57(f) - human health)
Details
-
741687-98-9
END Endocrine disrupting properties (Article 57(f) - human health)
Details
-
852541-30-1
END Endocrine disrupting properties (Article 57(f) - human health)
Details
-
852541-25-4
END Endocrine disrupting properties (Article 57(f) - human health)
Details
701-394-3
1782069-81-1
END Endocrine disrupting properties (Article 57(f) - human health)
Details
253-242-6
36861-47-9
END Endocrine disrupting properties (Article 57(f) - human health)
Details
201-025-1
77-40-7
END Endocrine disrupting properties (Article 57(f) - human health)
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
202-318-7
94-26-8
END Endocrine disrupting properties (Article 57(f) - human health)
Details
224-208-8
4247-02-3
END Endocrine disrupting properties (Article 57(f) - human health)
Details
-
-
END Endocrine disrupting properties (Article 57(f) - human health)
Details
239-139-9
15087-24-8
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
243-816-4
20427-84-3
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
230-770-5
7311-27-5
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
618-344-0
9002-93-1
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
687-832-3
1119449-37-4
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
687-833-9
1119449-38-5
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
248-743-1
27942-27-4
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
219-682-8
2497-59-8
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
604-395-6
14409-72-4
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
247-816-5
26571-11-9
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
-
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
621-341-7
2315-61-9
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
205-426-2
140-66-9
Skin Irrit. 2; Eye Dam. 1
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
257-907-1
52427-13-1
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
635-388-6
521947-27-3
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
635-389-1
186825-36-5
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
635-391-2
142731-63-3
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
635-696-0
186825-39-8
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
217-862-0
1987-50-4
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
-
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
284-325-5
84852-15-3
Repr. 2; Acute Tox. 4; Skin Corr. 1B
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
-
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
-
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
1 - 2.5 moles ethoxylated
500-315-8
127087-87-0
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
1 - 2.5 moles ethoxylated
500-045-0
26027-38-3
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
202-679-0
98-54-4
Repr. 2; Skin Irrit. 2; Eye Dam. 1
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
621-345-9
2315-67-5
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
300-298-5
93925-00-9
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
234-284-4
11066-49-2
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
609-346-2
37205-87-1
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
246-672-0
25154-52-3
Repr. 2; Acute Tox. 4; Skin Corr. 1B
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
1 - 2.5 moles ethoxylated
500-209-1
68412-54-4
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
500-024-6
9016-45-9
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
931-755-2
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
939-993-9
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
931-756-8
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
931-753-1
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
931-754-7
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
-
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
938-618-6
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
932-998-7
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
250-339-5
30784-30-6
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
201-280-9
80-46-6
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
241-427-4
17404-66-9
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
247-770-6
26543-97-5
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
203-199-4
104-40-5
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
608-492-4
3050-88-2
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
276-743-1
72624-02-3
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
291-844-0
90481-04-2
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
618-541-1
9036-19-5
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
939-460-0
1471311-26-8
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
939-460-0
1471311-26-8
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
show/hide
Phenol, p-sec-nonyl-, phosphite EC / List no: - | CAS no: 106599-06-8
Tris(nonylphenyl) phosphite EC / List no: 247-759-6 | CAS no: 26523-78-4
tris(4-nonylphenyl, branched) phosphite EC / List no: 701-028-2 | CAS no: -
Phenol, 4-nonyl-, phosphite (3:1) EC / List no: 608-492-4 | CAS no: 3050-88-2
Phenol, p-isononyl-, phosphite (3:1) EC / List no: - | CAS no: 31631-13-7
799-976-5
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
247-759-6
26523-78-4
Skin Sens. 1
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
203-615-4
108-78-1
Carc. 2; STOT RE 2
HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)
E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment)
Details
206-793-1
375-73-5
HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)
E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment)
Details
-
-
HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)
E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment)
Details
219-514-3
2451-62-9
Muta. 1B; Acute Tox. 3; STOT RE 2; Eye Dam. 1; Skin Sens. 1
M Mutagen (article 57b)
Details
TEPIC-H
423-400-0
59653-74-6
Muta. 1B; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
M Mutagen (article 57b)
Details
221-695-9
3194-55-6
Repr. 2; Lact.
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
247-384-8
25973-55-1
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
223-346-6
3846-71-7
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
287-476-5
85535-84-8
Carc. 2
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
281-985-6
84082-38-2
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
307-451-5
97659-46-6
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
283-930-1
84776-06-7
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
287-504-6
85536-22-7
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
701-376-5
1372804-76-6
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
287-477-0
85535-85-9
Lact.
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
283-931-7
84776-07-8
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
285-195-2
85049-26-9
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
272-924-4
68920-70-7
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
263-004-3
61788-76-9
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
603-801-9
134237-50-6
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
204-371-1
120-12-7
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
205-883-8
191-24-2
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
603-802-4
134237-51-7
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
214-604-9
1163-19-5
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
200-268-0
56-35-9
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
208-764-9
541-02-6
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
950-299-5
-
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
208-762-8
540-97-6
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
205-912-4
206-44-0
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
603-804-5
134237-52-8
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
show/hide
alpha-hexabromocyclododecane EC / List no: 603-801-9 | CAS no: 134237-50-6
1,2,5,6,9,10-hexabromocyclodecane EC / List no: 221-695-9 | CAS no: 3194-55-6
beta-hexabromocyclododecane EC / List no: 603-802-4 | CAS no: 134237-51-7
gamma-hexabromocyclododecane EC / List no: 603-804-5 | CAS no: 134237-52-8
Hexabromocyclododecane EC / List no: 247-148-4 | CAS no: 25637-99-4
247-148-4
25637-99-4
Repr. 2; Lact.
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
UVCB substances consisting of more than or equal to 80% linear chloroalkanes with carbon chain lengths within the range from C14 to C17
show/hide
Tetradecane, chloro derivs. EC / List no: - | CAS no: 198840-65-2
di-, tri- and tetrachlorotetradecane EC / List no: 950-299-5 | CAS no: -
Alkanes, C14-16, chloro EC / List no: 701-376-5 | CAS no: 1372804-76-6
Alkanes, C14-17, chloro EC / List no: 287-477-0 | CAS no: 85535-85-9
799-971-8
-
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
209-136-7
556-67-2
Repr. 2
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details

Export search results to: